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ABSTRACT
Cis-acting short sequence motifs play important
roles in alternative splicing. It is now possible
to identify such sequence motifs as conserved
sequence patterns in genome sequence alignments.
Here, we report the systematic search for motifs in
the neighboring introns of alternatively spliced
exons by using comparative analysis of mammalian
genome alignments. We identified 11 conserved
sequence motifs that might be involved in the regu-
lation of alternative splicing. These motifs are not
only significantly overrepresented near alternatively
spliced exons, but they also co-occur with each
other, thus, forming a network of cis-elements,
likely to be the basis for context-dependent regula-
tion. Based on this finding, we applied the motif co-
occurrence to predict alternatively skipped exons.
We verified exon skipping in 29 cases out of 118
predictions (25%) by EST and mRNA sequences in
the databases. For the predictions not verified by
the database sequences, we confirmed exon
skipping in 10 additional cases by using both RT–
PCR experiments and the publicly available
RNA-Seq data. These results indicate that even
more alternative splicing events will be found with
the progress of large-scale and high-throughput
analyses for various tissue samples and develop-
mental stages.
INTRODUCTION
Alternative splicing is a cellular process that provides
distinct, context-dependent isoforms of genes to generate
proteomic diversity (1), and is regulated in a tissue- and
developmental stage-speciﬁc manner. The fraction of
human genes that undergo alternative splicing had been
ﬁrst estimated as  40% based on mRNA and EST
sequence data (2,3). It has dramatically increased with
the progress of microarray and high-throughput
sequencing technologies, and the current estimate is as
high as 74–95% of multiexon genes in human (4–6).
Deciphering the set of rules that govern the regulation
of alternative splicing has been an important step toward
understanding the mechanisms of alternative splicing
(7–9). Besides the core splice signals in splice site selection,
there are two major groups of cis-acting regulatory se-
quences for both constitutive and alternative splicing:
exonic and intronic splicing regulators. The accumulation
of cDNA and EST sequences, and the determination of
the human genomic sequences have made it possible to
computationally analyze exonic splicing regulators
(10,11). However, until recently, it had been difﬁcult to
identify intronic splicing regulators by comparative
genomic approaches because of the lack of sequence in-
formation of introns in other mammalian species than
human.
The progress of genome sequencing projects of mam-
malian species has changed the situation, and now we can
make use of genome sequence alignments to identify not
only intronic splicing regulators but also various cis-
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the purifying selection acting on functionally important
sites, regulatory elements evolve much more slowly than
the rest of non-functional sequences. Thus, highly
conserved sequences in the genome alignments can be con-
sidered as candidate regulatory elements (12). Analyses in
this direction successfully identiﬁed many cis-elements in
promoter and 30-untranslated regions (13) and insulator
sites (14). Although it has been reported that many of the
alternative splicing events are species-speciﬁc, i.e. they are
not well conserved even among mammalian species (15–
17), several studies have shown that genome alignments
can be used to identify potential intronic splicing regula-
tors (18–21).
In alternative splicing, not only a single motif can
regulate spatio-temporal patterns of isoforms, but there
must be combinatorial mechanisms to achieve complex
regulation. To address this issue, we ﬁrst identiﬁed
highly signiﬁcant potential intronic splicing regulators by
using genome sequence alignments of mammalian species.
Then we analyzed the relationships among these potential
regulatory elements in terms of their co-occurrence in the
intronic sequences.
MATERIALS AND METHODS
mRNA sequences and their coordinates on the
human genome
To detect alternatively skipped exons, we used high-quality
non-redundant mRNAs from human in the Reference
Sequence (RefSeq) Database (22) (release 16, March
2006, http://www.ncbi.nlm.nih.gov/RefSeq). There are
several categories in the RefSeq mRNAs, and we only
used well-annotated mRNA sequences, i.e. ‘reviewed’,
‘provisional’, and ‘validated’. For our purposes, this
high-conﬁdent set of exon skipping is more effective than
using all possible event on the cost of false positives, e.g. by
including EST sets. The ﬁnal number of the mRNA se-
quences we obtained is 21754. These mRNA sequences
are mapped on the human chromosomes (hg18, March
2006, http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
bigZips/chromFa.zip) by using the BLAT program (23)
to determine the coordinates on the human genomic se-
quences. For each gene, we compared the structure and
coordinates of the transcripts to identify skipped exons.
Here, we considered an exon as skipped if: (i) the exon is
present in a transcript but completely absent in another
one; and (ii) the 30-end of the upstream exon and
the 50-end of the downstream exon have exactly the same
coordinates. In total, we identiﬁed 1736 skipped exons in
1473 genes.
Genome sequence alignment
The genome sequence alignments of vertebrate gen-
omes generated by the TBA program (24) were
downloaded from the UCSC Genome Browser Database
(25) (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
multiz17way). Although the genome alignment contains
17 species, we focused only on mammalian genomes
(12 species; release date and the assembly identiﬁers are
in the parenthesis): human (March 2006, hg18), chimpan-
zee (November 2003, panTro1), macaque (January 2006,
rheMac2), mouse (February 2006, mm8), rat (November
2004, rn4), rabbit (May 2005, oryCun1), dog (May 2005,
canFam2), cow (March 2005, bosTau2), armadillo (May
2005, dasNov1), elephant (May 2005, loxAfr1), tenrec
(July 2005, echTel1) and opossum (January 2006,
monDom4).
Counting conserved pentamers in the ﬂanking introns
of the skipped exons
We searched for intronic splicing regulators within introns
1000-bases upstream and downstream of the skipped exon
(Figure 1). We adopted this length cutoff according to
some related studies (17,26,27). The 60 residues at the
upstream of 30 splice site of the skipped exon and the 5
residues at the downstream of the 50 splice site of the
skipped exon are excluded from the analysis because
these regions contains splice site signals, polypyrimidine
tract and branch point sequences, which are rather highly
conserved and might bias our analysis. We are aware that
some motifs might exist in these regions, but they will
again come at the cost of false positives. If the ﬂanking
intron of the skipped exon is shorter than 1000 bases, then
only the region up to the neighboring exon is taken. In
such cases, the 60 residues upstream of 30 splice site of the
neighboring exon and the 5 residues downstream of
50 splice site of the neighboring exon are also excluded
from the analysis to ensure that the region does not
contain splice site signals, polypyrimidine tract, or
branch point sequences.
Then we retrieved the multiple sequence alignments of
genomic sequences corresponding to these regions, and
searched for strictly conserved pentamers among at least
10 mammalian species. Here, we masked the regions that
are highly conserved (>85% identity) for more than
50-residues usually cis-elements for alternative splicing
3„ splice site 5„ splice site
Discard 5 bases
to exclude splice site signal
Discard 60 bases
to exclude
 - splice site signal
 - polypyrimidine tract
 - branch point sequence
1000 bp 1000 bp
Figure 1. The regions analyzed to search for intronic splicing regula-
tors. The skipped exon is shown in gray box. The regions analyzed are
shown in gray arrows. If the ﬂanking intron of the skipped exon is
shorter than 1000 bases, then only the region up to the neighboring
exon are taken. In such case, the 60 residues upstream of 30 splice site
of the neighboring exon and 5 residues downstream of the 50 splice site
of the neighboring exon are also excluded from the analysis to ensure
that the region does not contain splice site signals, polypyrimidine tract,
or branch point sequences.
Nucleic Acids Research, 2010,Vol.38, No. 22 7917are much shorter and such a long stretch of conserved
region might contain unannotated RNA genes
embedded within introns or unannotated exons, and
counting these conserved regions would bias the
analysis. These cutoffs are taken from the average length
and sequence identity of orthologous exons between
human and mouse (28). In counting conserved pentamers,
simple repeats, e.g. runs of Ts (TTTTTTTTTT), are
counted only once to prevent over counting.
Statistical signiﬁcance of conserved pentamers
To assess the statistical signiﬁcance of the conserved
pentamers, ﬁrst we counted the number of pentamers
that are strictly conserved in at least 10 mammalian
genomes in the region deﬁned above. We also counted
the number of pentamers that are not conserved in the
same regions in human. As a control, we counted the
numbers of both conserved and unconserved pentamers
in the intron between the constitutive exons. For this,
we used the same RefSeq gene set (1473 genes), in which
we identiﬁed exon skipping, and deﬁned an exon as con-
stitutive if there are at least three transcripts for a gene and
all the transcripts have exactly the same exon. We set these
criteria to minimize the effect of alternative splicing not
observed in the current RefSeq database. Then we applied
Fisher’s exact text to evaluate the speciﬁc enrichment of
the conserved pentamers in the ﬂanking introns of the
skipped exons.
Recent studies have shown that the RNA-Seq
method, the transcriptome analysis using next-generation
sequencing platforms, reveals more instances of alterna-
tive splicing events than the analyses by using mRNA and
EST sequences (5,6). This means that some of the consti-
tutive exons that we used as a control set might be alter-
natively skipped, and might affect our ability to detect
motifs. To measure the amount of such cases, we
analyzed the exons in our data sets with the RNA-Seq
data (5,6) obtained from the GEO database (29). We clas-
siﬁed an exon as skipped if there are at least three reads
that cover ﬁve or more nucleotides of either the upstream
and downstream exon. Using the RNA-Seq data from
Wang et al. (6), only 68 exons out of 3086 exons that we
classiﬁed as constitutive exons by RefSeq mRNAs are
observed to be skipped. We also carried out the same
analysis using the RNA-Seq data from Pan et al. (5),
and detected only 37 exons out of the 3086 constitutive
exons as skipped. By merging the results obtained
from these two RNA-Seq data, total of 88 (2.9%)
constitutive exons are detected as skipped, indicating
that the quality of the classiﬁcation for constitutive
exons by using RefSeq mRNAs is high enough to be
used as the control.
Since our analysis is based on the conserved pentamers,
we may get two or more pentamers from a single highly
conserved motif of the length longer than 5nt. We
grouped these pentamers as clustered motifs according
to the overlap in position with highly signiﬁcant probabil-
ity [P<1.0 10
 12 by the cumulative hypergeometric dis-
tribution function (30); see below].
Statistical signiﬁcance of co-occurrence of motifs
The statistical signiﬁcance of motif co-occurrence was
calculated by the cumulative hypergeometric distribution
function (30). The probability, P, of obtaining the number
of co-occurrence equal to or higher than c purely by
chance is calculated by the following equation:
Pc ðÞ¼
X min m1,m2 ðÞ
i¼c
m1
i
  
N   m1
m2   i
  
N
m2
   ð1Þ
where m1 and m2 are the number of motif1 and motif2,
respectively, N the total number of introns examined and i
the summation index. For example, if the numbers of
motif1 and motif2 are 60 and 80, respectively, and 20 of
them co-occur in the total of 800 introns, then the prob-
ability to have such co-occurrence purely by chance is
calculated as 1.8 10
 7.
Prediction of skipped exons in the human gene set
To evaluate whether the motif co-occurrence can be a
strong indicator for alternative splicing, we predicted
exon skipping in the Ensembl exon set (31) by using the
motif co-occurrence and the conservation among the
mammalian genomes. For this prediction, we used all
Ensembl exons except for those identical with the exons
identiﬁed in the initial RefSeq analysis. We considered a
prediction to be correct if there is at least one for
each transcript variant in ESTs from dbEST or mRNAs
from GenBank. As a control, all internal exons of the
Ensembl gene set are evaluated. The success rates
between the predicted set and the control set are evaluated
by  
2 test.
Exon skipping supported by RNA-Seq data
To further conﬁrm our predictions of exon skipping, we
used RNA-Seq data (5). From the GEO database at NCBI
(29), we downloaded RNA-Seq data (the GEO accession
number: GSE13652) for the following six tissues: brain,
cerebral cortex, heart, liver, lung and skeletal muscle. For
each prediction of exon skipping, we created a 64-nt-long
splicing junction sequence, the 50- and 30-half of which are
from upstream and downstream exons, respectively (5).
Next, we mapped the short sequence reads on to the
splicing junction sequence by using the bowtie program
(32). To eliminate false positive hits, we did not allow
any mismatches/indels. We also set a condition that at
least ﬁve nucleotides of the read should overlap either
the upstream or downstream exon.
To see if more tissue data can improve the detection rate
of exon skipping events, we applied a re-sampling method
to the existing data. Since we have data for six tissue
samples, we counted the number of supported exon
skipping for all possible combination from one to six
samples, and the number of supported exon skipping is
plotted along the number of tissue samples we used.
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ampliﬁcation of splicing products
Poly (A)+ RNAs from the following 12 human tissues
(or brain regions) were purchased from Clontech
Laboratories, Inc.(Mountain View, CA): fetal brain,
hippocampus and amygdala of adult brain, skeletal
muscle, bone marrow, prostate, thymus, pancreas, heart,
liver, kidney and testis. We did not use any cancer cell
lines, because it is known that there are many
cancer-speciﬁc alternative splicing events, which might
bias the analysis (33). Using the poly (A)+ RNAs,
single-stranded cDNAs were prepared as described previ-
ously (34). The polymerase chain reaction using the
single-stranded cDNA as a template [Reverse
transcription polymerase chain reaction (RT–PCR)] was
carried out with an LA-Taq polymerase (Takara Bio, Inc.,
Shiga, JAPAN) in the presence of thermostable Rec A
protein as described previously (35). Using thermostable
Rec A, we could use the common PCR cycling conditions
for all the primer sets given in Supplementary Table S1 as
follows: denaturation step, 95 C for 1min, 30 cycles of
PCR consisting of 95 C for 15s, annealing at 52 C for
30s and extension at 72 C for 45s. The ﬁnal PCR cycle
was followed by additional extension reaction at 72 C for
5min. The PCR products were resolved on 4% NuSeive
GTG agarose gel (Takara Bio Inc.) and then detected by
ﬂuorescent staining with ethidium bromide. After isola-
tion of the PCR products on agarose gel, DNA sequencing
of the PCR products was done on an ABI 3130 (Applied
Biosystems, Foster City, CA) using a Big Dye Terminator
v3.1 Cycle Sequencing kit (Applied Biosystems).
RESULTS AND DISCUSSION
Identiﬁcation of intronic splicing regulatory motifs by
using genome alignments
To systematically identify and predict sequence motifs
that point to the regulation of alternative splicing, we
focused on alternatively skipped exons as they are
straightforward to measure and are the most frequent
type of alternative splicing (36). We compared 21754
human mRNAs from the well-curated RefSeq database,
and identiﬁed 1736 skipped exons in 1473 genes (see
Supplementary Table S2 for the list of skipped exons).
It has been shown that a certain fraction of alternative
splicing is not conserved between human and mouse (16).
This means that some alternatively spliced exons that we
identiﬁed by the comparison of human RefSeq mRNAs
might not be alternatively spliced in the other species.
However, if the existence of conserved sequences around
the exons that are alternatively spliced in human, then this
implicates that the conserved sequences is also involved in
alternative splicing in other species. Recent studies have
also shown that the inter-species comparison by using
genome alignments makes it possible to identify many
intronic splicing regulators (18–20). Based on these
approaches, we retrieved ﬂanking introns for each alter-
natively skipped exon and constructed alignments of
12 mammalian genomic sequences corresponding to the
regions. After ﬁltering out highly conserved 50 donor
and 30 acceptor sites, polypyrimidine tracts and
branch-point sites (Figure 1), we recorded all pentamers
that were strictly conserved in at least 10 mammalian
genomic sequences. We chose pentamers based on the
fact that many splicing factors recognize speciﬁc sequences
of 4–6nt in length (37,38). Another reason to use penta-
mers is that the number of all possible patterns is higher
(4
5=1024) than that for tetramers (4
4=256), which
might help to reduce false counts of patterns. The statis-
tical power comes at the cost of possibly missing some
short and degenerated patterns, such as the Nova
binding motif (YCAY) (39) or the CU-rich element (40).
Longer patterns can be detected though by combining
overlapping patterns (see below). To assess whether
these pentamers are speciﬁcally conserved in the ﬂanking
introns of skipped exons, we compared the frequencies of
these pentamers with those in the introns ﬂanking consti-
tutive exons as a control and calculated a statistical sig-
niﬁcance by Fisher’s exact test. Then we sorted the
pentamers according to the Fisher’s P-values, and listed
18 pentamers with P<1.3 10
 4 (Table 1; see
Supplementary Table S3 for the complete list of motifs
and the corresponding genes). The cutoff was selected as
the highest P-value for the pentamer with experimental
support (see below). Some of these pentamers are
sub-strings of longer motifs; therefore, we clustered these
according to their overlaps in the genomic sequence and
arrived at a total of 11 distinct motifs.
Although we masked highly conserved regions longer
than 50-residues (see ‘Materials and Methods’ section),
there are only 64 intronic regions for the skipped exons
out of the total of 1736 skipped exons. As a result, even
without the masking, we obtained very similar statistics
for the pentamers.
The most signiﬁcant motif is GCATG (Table1). This
pentamer is conserved 157 times in the ﬂanking introns
of skipped exons, which corresponds 103 distinct exons
from 98 genes. This pentamer, together with the second
most signiﬁcant one, forms a well-characterized hexameric
motif, TGCATG, which has been identiﬁed as binding site
for the Fox-1 protein (37). In some genes this motif is
highly conserved among vertebrates (26), and it is also
highly frequent in the neighboring introns of skipped
exons in nematodes (38). The third and fourth of the
pentamers (Table 1) form a hexameric motif, ACTAAC.
This motif, which is similar to the branch-point consensus
sequence, has been recently identiﬁed as speciﬁcally
enriched in muscle-regulated alternative splicing (27).
Among the other signiﬁcantly overrepresented motifs,
some are similar, but not identical, to some previously
predicted motifs (Table1). For example, the GTGGTGG
G motif is very similar to the purine-rich element that has
been shown to be involved in the regulation of alternative
splicing in thyroid hormone receptor mRNA (41). This
motif is also similar to the G-rich motif, (A/U)GGG,
which has been identiﬁed as an intronic splicing
enhancer (42). Additional novel regulatory motifs are
likely to be enriched in our list, but are below our stringent
P-value cutoff (see Supplementary Table S4 for all the
pentamers sorted by the P-values).
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different studies varies a lot, e.g. including 100 bases (21)
or up to 300 bases (9) from the splice sites. To see the
distribution of conserved pentamers around the ﬂanking
introns of alternatively skipped exons, we counted the
number of 18 pentamers listed in Table 1 (Figure 2). For
both upstream of the 30 splice sites and downstream of the
50 splice sites, the conserved pentamers are more frequent
within 300 bases from the splice sites, but we still see some
conserved motifs even up to 1000 bases. Although there
must be bona ﬁde motifs in the regions >1kb apart from
the splice sites, the inclusion of those compromises the
selectivity of the analysis.
Comparison with the other data sets
We compared the 18 signiﬁcant pentamers with recently
predicted intronic splicing regulators (6,18–20,43)
(Table 2). Although all the statistically signiﬁcant penta-
mers are also listed in the other data sets at least as a
sub-string of the longer patterns, there is no single data
set that covers all the 18 pentamers. Four pentamers, GT
GGG, AAAGG, GTGGT and GGTGG, which corres-
ponds to two clustered motifs, GTGGTGGG and AAA
GG, exist only as a sub-string of the longer patterns in the
other data sets. In some data sets, even well-known
patterns are missing. For example, the most signiﬁcant
pentamer in our list is missing in three out of four sets
of motifs identiﬁed by Churbanov et al. (20). Another
example is ACTAAC, which is missing not only in
the three sets of the motifs identiﬁed by Churbanov
et al. (20), but also missing in the list of intron-identity
elements identiﬁed by Zhang et al. (43). Most of the penta-
mers we identiﬁed, especially the ones with lower P-values,
are also represented in the donor/acceptor intronic
ﬂanking region by Voelker et al. (18) and the conserved
words located in the upstream/downstream of internal
exons analyzed by Yeo et al. (19).
Analysis of genome alignments with various groups
of species
To measure the changes in the power of motif detection
with several groups of mammalian species, we analyzed
the genome alignments for each group of species. Here,
we analyzed the following ﬁve groups of species: (i) human
and mouse; (ii) Euarchontoglires; (iii) Boreouetheria;
(iv) placental mammals; and (v) mammals (see Table 3
for the species in each group). Since we do not know
bona ﬁde cis-elements in the genome-wide scale, we
focused only on the pentamer, GCATG, which is the
part of the well-known cis-element for alternative
splicing, and counted the number of the conserved penta-
mers for each groups of species (Table 3). If genome align-
ments of only human and mouse are analyzed, we obtain
more than 300 motifs around skipped exon. But, at the
same time, higher number of motifs are found in the
introns around constitutive exons, indicating that
analyzing only two species, human and mouse, would
give a higher ratio of false positive predictions. As a
result, we have a higher P-value by Fisher’s exact test
comparing to the sets with more species.
Although the divergence within the group is similar
between the set consists of human and mouse (the ﬁrst
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18 pentamers listed in Table 1 are counted in the ﬂanking introns of
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Table 1. Conserved pentamers with statistical signiﬁcance
Rank Conserved
pentamer
Clustered
motif
P-value
a
1 GCATG TGCATG 1.0 10
 29
2 TGCAT TGCATG 1.4 10
 20
3 ACTAA ACTAAC 7.5 10
 12
4 CTAAC ACTAAC 9.8 10
 10
5 TGCTG CTGCTGC 8.7 10
 08
6 GCTGC CTGCTGC 3.3 10
 07
7 TGCTT CTTGCTT 7.2 10
 06
8 CTTGC CTTGCTT 8.2 10
 06
9 GTGGG GTGGTGGG 1.1 10
 05
10 TTTCT TTTCT 1.2 10
 05
11 AAGAT AAGAT 3.6 10
 05
12 TGGAA TGGAA 4.2 10
 05
13 GCTAA GCTAA 5.6 10
 05
14 CTGCT CTGCTGC 5.6 10
 05
15 AAAGG AAAGG 6.8 10
 05
16 GTGGT GTGGTGGG 9.8 10
 05
17 TCTTG TCTTG 1.2 10
 04
18 GGTGG GTGGTGGG 1.3 10
 04
Pentamers are sorted by P-values. The pentamers that cover only a
part of known motifs are excluded from the list (see Supplementary
Table S4 for a complete list of the pentamers sorted by P-value).
aP-values are calculated by Fisher’s exact test.
7920 Nucleic Acids Research, 2010,Vol.38, No. 22row in Table 3) and Euarchontoglires (the second row in
Table 3), number of the GCATG pentamers and the
associated P-value are very different. This indicates that
adding more internal species can drastically improve the
power of the cis-element detection.
By comparing Euarchontoglires and Boreouetheria,
number of the conserved GCATG pentamers around the
skipped exons drops from 177 to 158. The difference in the
number of motifs might represent the existence of
species-speciﬁc motifs, i.e. the motifs exist only in
Euarchontoglires but do not exist neither in dog nor in
cow genomes. Or another explanation for this is that the
motifs might not be aligned properly because of the inclu-
sion of distant species.
Motifs are often co-occur in the same ﬂanking introns
When analyzing the genomic positions of these motifs, we
found that a signiﬁcant number of motifs co-occur in the
same ﬂanking introns of skipped exons. One such example
is found in the downstream of the skipped exon of the
nuclear distribution element-like protein (NDEL1;
Figure 3A). The two motifs, ACTAAC and TGCATG,
are strictly conserved in the 12 mammalian species, and
there are no highly conserved segments around this region
except for these two motifs. It has been shown that the
exon is selectively included in the transcript in melanocyte
but not in melanoma (44). This cell line-speciﬁc differen-
tial expression of the exon suggests a tightly regulated
mechanism for the alternative splicing of the exon, and
the co-occurring motifs are the most likely candidates to
mediate this process. Another example is found in the
downstream of the skipped exon of myosin binding
protein C (MYBPC1), where TGCATG and TGCTT,
are separated by 19–21 residues (Figure 3B). The two
examples illustrate that binding of the splicing regulator
to the individually well-characterized TGCATG motif
appears to be ﬁne-tuned by other factors binding to
other neighboring sites. This led to the hypothesis that
different motif pair combinations might provide the sig-
nature for context-dependent splicing.
By applying a cumulative hypergeometric distribution
function [Equation (1)], we obtained statistically signiﬁ-
cant co-occurring motifs. To determine the cutoff of
co-occurrence P-value, we compared the distributions of
the P-values calculated from all possible pairs among the
18 highly signiﬁcant pentamers and the P-values
calculated from randomly selected pairs of pentamers
(Figure 4). Based on these distributions, we selected the
two cutoffs, P<1.0 10
 5 and P<1.0 10
 4, for statis-
tically signiﬁcant co-occurrence of motifs. Although we
restricted our analysis only to the highly signiﬁcant
motifs listed in Table 1, various combinations of
co-occurring motifs are signiﬁcant, forming a complex
network (Figure 5), likely to be the basis for context-
dependent regulation. Very recently, Barash et al. (9) pre-
sented three networks, which consist of motifs and other
features, to predict tissue-dependent alternative splicing.
Some of the edges in our network are also present in
their networks. For example, the edge showing the
frequent association of TGCATG and ACTAAC in our
Table 2. Comparison of the 18 pentamers with the patterns in other data sets
Voelker et al. (18) Yeo et al. (19) Churbanov et al. (20) Wang et al. (6) Zhang et al. (43)
Donor
a Acceptor
a Upstream
b Downstream
b 30-ISE
c 30-ISS
c 50-ISE
c 50-ISS
c 30SS-intronic
d 50SS-intronic
d IIE
e
(819) (1007) (1069) (911) (814) (1032) (478) (174) (175) (187) (708)
GCATG M M s M – s – – s s s
TGCAT M M M M s – – – s s s
ACTAA M M M s s – – – s s –
CTAAC M M M M M – – – s s –
TGCTG M M s s s s – – s – s
GCTGC M s s s – s s – s – –
TGCTT M M M M – – – – – – s
CTTGC M s M s s s – – s s s
GTGGG s – – s s s s s – – s
TTTCT M M s s s – s – – – s
AAGAT – – – M – s – – s s –
TGGAA s M s s – s – – – – s
GCTAA s M M s s – – – s – –
CTGCT M M M M s – – – – – s
AAAGG s s – – – s – s s – –
GTGGT – – s – – s – – s – s
TCTTG s M M s s – – – s s s
GGTGG s – – s s s s s s – s
The total number of predicted motifs are indicated in the parenthesis under each data set.
aSigniﬁcantly conserved n-mers found in the donor/acceptor intronic ﬂanking region (18).
bConserved words that are located upstream/downstream of internal exons (19).
c30-/50-splice site-related intronic splicing silencers/enhancers (20).
d30-/50-splice site intronic motifs (6).
eIntron-identity elements (43).
M, exact match; s, the pentamer is included as a sub-string of the longer pattern; –, no match found.
Nucleic Acids Research, 2010,Vol.38, No. 22 7921network is also present in the network for muscle-speciﬁc
inclusion of alternative exons (9). Another pair of motifs
in our network, TTTCT and TGCATG, can be found in
the network for central nervous system-speciﬁc inclusion
of alternative exons (9). We have these edges (i.e. pairs of
motifs) in the same network because we do not take
tissue-speciﬁcity into account. We consequently analyzed
functional GO terms and tissue-speciﬁc isoforms in EST
and cDNA databases, but did not see any signiﬁcant as-
sociation of the co-occurring motifs and functional classes
or tissue-speciﬁcity (data not shown).
Prediction of alternatively skipped exons by
motif co-occurrence
We then tested whether the co-occurrence of the identiﬁed
motifs in ﬂanking introns of an exon can be applied to
predict novel alternatively skipped exons. For this, we
extended our analysis to the ﬂanking introns of all
annotated exons in the human Ensembl gene set,
Nuclear distribution element-like protein (NDEL1)
789 1 0
human       chr17            +    8307472  T-------CTGGTTTTACTAACTGCATGGGGCTGACTCAGCTTTAACCAACTTACA
chimpanzee  chr19_random     -   30142772  T-------CTGGTTTTACTAACTGCATGGGGCTGACTCAGCTTTAACCAACTTACA
macaque     chr16            +    8210674  T-------CTGGTTTTACTAACTGCATGGGGCTGACCCAGCTTTAACTGACTTACA
rat         chr10            -   55585562  A-------CTGGTTTTACTAACTGCATGGGGTGGACTCAGCTTTAACCAACTTTTA
mouse       chr11            -   68642293  A-------CTGGTTTTACTAACTGCATGGGGTGGACTCAGCTTTAACCAACTTTTA
rabbit      scaffold_173547  -      98957  A-------TTGGTTTTACTAACTGCATGGGGCTGACTCGGCTTTAACCAACTTACA
cow         chr2             +   77838750  A-------CCGGGTTTACTAACTGCATGGGGCTGACTCTACTTTAACCAGCTTCCA
dog         chr5             +   36225127  A-------CTGGTTTTACTAACTGCATGGGGCTGACTCTGCTTTAACCAACTTACA
armadillo   scaffold_34325   +       3294  A-------CTGGTTTTACTAACTGCATGGGGCTGACTCAGCTTTAATCAACTTACA
elephant    scaffold_1864    -      40945  A-------CTGGTTTCACTAACTGCATGGGGCTGACTCAGC-TTAACCAACTTACC
tenrec      scaffold_319312  +      52966  AACCCAGGCTGGTTTTACTAACTGCATGGGGCTGGCTCAGC-TTCAGCCACTCGCA
opossum     chr2             +  281969155  A-------TTCAGCATACTAACTGCATGGGCCTAACTTAGTTCAATTCAGCAAACA
                                                           **************     *              *
Myosin binding protein C (MYBPC1)
29 30 31 32 33
human       chr12            +  100600634  TGCACCTTGCATGTAAAGCTTGA-CTTTCTCATTTGCTTTTA-ATTG-TACCCCTT
chimpanzee  chr10            +  103039871  TGCACCTTGCATGTAAAGCTTGA-CTTTCTCATTTGCTTTTA-ATTG-TGCCCCTT
macaque     chr11            +  102880335  TGCACCTTGCATGTCAAGCTTGA-CTTTCTCATTTGCTTTTA-ATTG-TACCTCTT
rat         chr7             -   25216277  CGCACTATGCATGTAAAGCTTGGTTTTTCTTGGTTGCTTTTA-ACCG-TATTTCTT
mouse       chr10            -   87951014  CGCATTTTGCATGTAAAGCTTGATTTTTCTTGGTTGCTTTTA-ACTGTTATTTCTT
cow         chr5             -   39941556  CGCACTTTGCATGTAAAGCTTGT-CTTTCTCTTTTGCTTTTA-ATTA-TATTTCTT
dog         chr15            +   43597447  CGCACTTTGCATGTAAAGCTTGA-CTTTCTCATTTGCTTTTC-ATTG-TATTTCTT
armadillo   scaffold_8886    +      32959  CGCACTTTGCATGTAAAGCTTGA-TTTTCTCTTTTGCTTTTA-ATTA-TATTTTTT
elephant    scaffold_1180    -     122105  CGCATTTTGCATGTAAAGCTTGA-CTTTCTCATTTGCTTTTA-ATTG-TATTTCTT
tenrec      scaffold_109390  -       5967  TGCCCTTTGCATGTAAAGCTTGC-CTTTCTCACGTGCTTCC--CCTG-TGCTTCCT
opossum     chr8             +   77201406  TGCATTTTGCATGTAAAGCTTGC-CTTTC-CTTCTGCTTTTAGACTG-TCCTCATT
                                            **    ******* *******   ****     *****         *      *
A
B
Figure 3. Examples of co-occurring motifs. (A) ACTAAC and TGCATG in the ﬂanking intron of the skipped exon of NDEL1 and (B) TGCATG
and TGCTT in the ﬂanking intron of the skipped exon of MYBPC1. The part of the gene structure around the skipped exon is shown above the
alignment with the exon numbers. The format of the alignment: the ﬁrst column, the name of the species; second column, chromosome or scaffold
identiﬁer; the third column, direction of the gene on the chromosome, the fourth column, position on the chromosome. Conserved residues are
indicated by asterisks under the alignments. Conserved motifs are indicated by colored boxes.
Table 3. GCATG motif in the genome alignments of various groups
of species
Species Conserved GCATG in the introns P-value
a
Around
skipped
exons
Around
constitutive
exons
Human+mouse 303 136 1.1 10
 23
Euarchontoglires
b 177 29 1.4 10
 33
Boreouetheria
c 158 17 6.4 10
 36
Placental mammals
d 140 21 6.8 10
 28
Mammals
e 157 26 1.0 10
 29
In the mammals set, we count the motif if it is strictly conserved at
least in 10 species.
aP-values are calculated by Fisher’s exact test.
bHuman, chimpanzee, macaque, mouse, rat, rabbit.
cHuman, chimpanzee, macaque, mouse, rat, rabbit, dog, cow.
dHuman, chimpanzee, macaque, mouse, rat, rabbit, dog, cow,
armadillo, elephant, tenrec.
eHuman, chimpanzee, macaque, mouse, rat, rabbit, dog, cow,
armadillo, elephant, tenrec, opossum.
7922 Nucleic Acids Research, 2010,Vol.38, No. 22excluding those identiﬁed in the initial RefSeq analysis.
Using co-occurrence and conservation in mammals of
the 11 signiﬁcant motifs (Table 1), we predicted another
118 alternatively skipped exons in the human Ensembl
gene set. Among these 118 exons, 29 (25%) of them
have clear indication of exon skipping based on an inde-
pendent comparison with dbEST and GenBank mRNAs
(Supplementary Table S5). This would be a lower estimate
of predictive power because of the limited, biased and
low-resolution EST coverage in terms of tissues and
temporal states. In contrast, of all internal exons in the
Ensembl gene set (167341 in total), only 15089 (9%) of
them seem to be skipped by comparison with dbEST and
GenBank mRNAs. This clearly indicates that the number
of exon skipping events is signiﬁcantly higher for the
exons with co-occurring motifs in the ﬂanking introns
(P=3.7 10
 9 by  
2 text). We further looked for the
supporting evidence for the exon skipping in our predic-
tions in recently published RNA-Seq data from six tissue
samples (5), and, in addition to the 29 annotated skipping
events, RNA-Seq data conﬁrmed 8 additional instances
(Supplementary Table S5). To see if more tissue data
can improve the detection rate of exon skipping, we
applied a re-sampling method to the existing data. The
results show that if we have RNA-Seq data for more
tissue samples, even more predictions of alternatively
skipped exons will be supported although the data are
still too sparse to develop a tissue code for exon
skipping (Figure 6). For the predictions with no EST
and mRNA support, we also randomly selected 10 pre-
dicted alternatively skipped exons together with 10
internal exons unlikely to undergo exon skipping and
carried out RT–PCR to actively search for the evidence
of exon skipping. In 12 tissue libraries, 3 of the 10 exons
predicted to be skipped were conﬁrmed to be skipped in
certain tissues, whereas no exon skipping was detected for
the 10 unpredicted exons as far as we examined
(Supplementary Table S6). For example, the skipped
form of the third exon of ENST00000256858, as well as
the included form, is detected in fetal brain and two
regions of adult brain (hippocampus and amygdala)
(Figure 7), while it is not skipped in all the other tissues
we tested (see Supplementary Figure S1 for all the results
of the PCR experiments). This not only conﬁrms the pre-
dictive power of motif combinations, but also the low
resolution of current transcriptome data with respect to
cell type and organism age. For the predictions that the
skipped forms have not been conﬁrmed by PCR experi-
ments, we cannot exclude the possibility that the
co-occurring motifs might work in a competitive
manner. In the future, the addition of other features,
such as exon/intron length and RNA secondary structure,
should improve the prediction accuracy (9).
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Figure 4. Distribution of the probability calculated by cumulative hypergeometric distribution function. The pairs among the statistically signiﬁcant
motifs are shown in orange and the scale for those is indicated as the vertical axis on the right. The randomly selected pairs are shown in cyan and
the scale for those is indicated as the vertical axis on the left.
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Figure 5. A network of co-occurring motifs. Each node represents a
motif. Number of skipped exons with the motif is indicated in the node.
If several pentamers consists of a single motif, the pentamers are shown
in the node. Each edge represents a pair of co-occurring motifs.
Number of skipped exons with a pair of co-occurring motifs is
indicated at the edge. Thick and thin lines indicate statistically signiﬁ-
cant co-occurrence, P<1.0 10
 5 and P<1.0 10
 4, respectively. The
nodes that are not connected with P<1.0 10
 4 are linked with dotted
lines to the closest motifs. The P-values for these edges are<1.0 10
 3,
except for the one links AAAGG (P<2.1 10
 3). The edge connecting
the same node indicates the signiﬁcant co-occurrence of the same motif.
Nucleic Acids Research, 2010,Vol.38, No. 22 7923In total, 39 exons out of 118 predictions are conﬁrmed
to be alternatively spliced (Supplementary Table S5). To
see if these 39 cases have some additional features
comparing to the rest of the 79 cases, ﬁrst we calculated
the distances of the motifs pairs. The average distances for
the conﬁrmed 39 cases and the rest of the 79 cases are
518.1 and 321.3 bases, respectively. Applying Mann–
Whitney U-test (45) to these two distributions of the
motif distances, we obtained z’=1.97, which corresponds
to P>0.01. Then we calculated secondary structure
forming potential around the motifs. For each motif, we
extracted the sequence from 50 bases upstream to 50 bases
downstream of the motif, and applied the RNAfold
program (46) to calculated possible folding energy. The
average folding energy values for the conﬁrmed 39 cases
and the rest of the 79 cases are  19.6 and  17.8kcal/mol,
respectively. The two energy distributions are compared
by Mann–Whitney U-test, which gives z’=2.56
(P>0.01). From these analyses, we do not see any statis-
tically signiﬁcant differences between the experimentally
conﬁrmed set and the set yet to be conﬁrmed at least for
these two features.
CONCLUSIONS
It has been shown that some distinct splicing factors work
together to regulate alternative splicing in some instances
(47–49). We show that such co-occurrence of the cis-
elements is not a special case for a certain pair of motifs
but it might be a common principle as almost all motifs
identiﬁed here form a network that might be the basis for
context-speciﬁc intronic splicing regulation. The
co-occurring elements might act in a cooperative or
competing manner to provide complexity in the regulation
of alternative splicing, for example, to achieve ﬁne-grained
tissue- or developmental stage-speciﬁc control. Recently
an experimental system has been devised to analyze
coordinated regulation of tissue-speciﬁc alternative
splicing (50), which will allow a more detailed analysis of
the regulation provided by the co-occurring elements
identiﬁed in this study. This kind of combinatorial regula-
tion is analogous to that of transcription, in which com-
binatorial usage of distinct transcription factors provide a
large variety of possibilities for gene expression patterns
(51), and this principle might, thus, widespread in
genomic regulation. Co-occurrence of cis-regulatory
elements also suggests that, although one element might
be sufﬁcient to explain the regulatory mechanism of alter-
native splicing under a given condition, other elements
might be necessary to fully explain the complex regulation
of alternative splicing.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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